Company performance
Current Price
as of Jan 10, 2025$87.43
P/E Ratio
N/A
Market Cap
$5.55B
Description
Blueprint Medicines Corp. is a precision therapy company, which engages in the invention of medicines for people with cancer and blood disorders. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.
Metrics
Overview
- HQCambridge, MA
- SectorHealth Technology
- IndustryBiotechnology
- TickerBPMC
- Price$87.43-3.53%
Trading Information
- Market cap$5.55B
- Float98.02%
- Average Daily Volume (1m)736,474
- Average Daily Volume (3m)684,892
- EPS-$2.06
Company
- Revenue$434.41M
- Rev growth (1yr)126.61%
- Net income-$56.28M
- Gross margin95.48%
- EBITDA margin-35.19%
- EBITDA-$45.11M
- EV$5.86B
- EV/Revenue13.49
- P/EN/A
- P/S12.76
- P/B17.72
Documents
SEC Filings
Factset Street Account
Earnings Calls
Factset